Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Nursing Home Staff Closest to Patients Are Least Likely to Get COVID VaccinesLowering Medicare Age Could Help Close Racial Gaps in Health Care: StudyHow Trust in Science Can Make You Vulnerable to 'Pseudoscience'Major Medical Groups Call for Mandatory COVID Vaccination for Health WorkersU.S. to Stick With International Travel RestrictionsPatients of Color Less Likely to Get Specialist Care Than White PatientsEven at Same Hospital, Black Patients Face More Complications Than WhitesMany Patients Billed for Preventive Care That Should Be Free: StudyDrug Makers Reach $26 Billion Deal on Opioid LawsuitsCOVID Drove Biggest Drop in U.S. Life Expectancy Since World War IIU.S. Issues Toughest Travel Alert for Britain As COVID Cases There ClimbLong Distance to Care Can Mean Worse Outcomes for Young Cancer PatientsCanada May Open Borders to Fully Vaccinated Americans by Mid-AugustWhy Many Black & Hispanic Americans Distrust COVID Vaccines$345 Million Settlement Proposed in EpiPen LawsuitsAHA News: How Healthy Is Your Neighborhood? Where You Live Can Greatly Affect Heart, Brain HealthExtreme Heat Hits Poorer Neighborhoods HarderFive Neutrogena and Aveeno Spray Sunscreens Recalled Due to BenzeneMany States Move to Ban Vaccine Mandates, Passports in Public SchoolsWHO Calls for Global Registry of Human Genome EditingMost Cancer Screenings Make Big Rebound After Pandemic DeclineBlack Churches Could Be Key to Boosting Vaccination RatesFDA Head Asks for Investigation Into Alzheimer's Drug ApprovalWhy Even the Healthy Need a Primary Care DoctorClimate Change Already Causes 5 Million Extra Deaths Per YearIs Medicare Overspending? Costco Prices Much Less for Generic DrugsLanguage Barriers Keep 25 million in U.S. From Good Health CareState Lotteries Don't Boost COVID Vaccination Numbers: StudyBlood Shortages Causing Surgery Delays Across U.S.Walmart to Offer Low-Priced InsulinCould Home Test for Colon Cancer Mean a Big Medical Bill to Come?Juul to Pay $40 Million in N.C. Case Over Vaping's Harm to TeensHospitals: One Reason COVID Is More Lethal for Black AmericansU.S. Supreme Court Strikes Down Challenge to Affordable Care ActHow Secure Is Your Health or Fitness App?Doctors May Be Overprescribing Opioids After SurgeriesMost Editors at Leading Medical Journals Are White, Study FindsAHA News: Why Everyone Should Care About Health Disparities – And What to Do About ThemUS to Send 500 Million COVID Vaccine Doses to Countries Desperate for ShotsThink You Can Skip That Annual Physical?  Think AgainYour Doctor Appointments Might Look Different Post-PandemicU.S. Blood Supply Is Safe From Coronavirus, Study FindsThink You Can Spot Fake News? Many Can'tTelehealth Is Growing in Use, Acceptance Among Americans: PollAHA News: Deep Disparities Persist in Who Gets Exposed to Secondhand SmokeMany Pre-Surgery Tests Are Useless, So Why Are Hospitals Still Using Them?U.S. Officials Say 50% of American Adults Are Now Fully VaccinatedMore Pot-Linked Poisoning Cases as Edibles' Popularity BoomsU.S. Issues Tough Travel Warnings for Japan Ahead of OlympicsScience Studies Most Likely to Be Wrong Are the Most Widely Read
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Could Home Test for Colon Cancer Mean a Big Medical Bill to Come?

HealthDay News
by By Robert Preidt and Robin Foster HealthDay Reporters
Updated: Jun 28th 2021

new article illustration

MONDAY, June 28, 2021 (HealthDay News) -- You decide to take a popular colon cancer screening test that can be performed at home, and it comes back positive. A follow-up colonoscopy is scheduled, but then you suddenly receive a large and unexpected medical bill.

That's what happened to a Missouri woman who was hit with $1,900 in medical expenses after using the popular at-home colon cancer screening test called Cologuard.

Before using the test, Lianne Bryant checked with her insurance company and was told the test would be fully covered, CBS News reported.

The Cologuard test came back positive, so Bryant had a follow-up colonoscopy, which was negative. But then, "I start getting statements from my hospital saying that I have a balance of $1,900," Bryant told CBS News. "I'm thinking, well, I certainly don't owe that much. I mean, that's not possible."

Under the Affordable Care Act, only routine screening tests are covered. Because Bryant's Cologuard result was positive, her follow-up colonoscopy was classified as a "diagnostic" test, which was not fully covered by her insurance. She would have been fully covered had she not used Cologuard first.

"I am mad because I pay so much every month for this insurance," Bryant told CBS News. "I just feel like I'm really getting raked over."

Luckily, Cologuard has a program to help people file an appeal if they get an unexpected bill for a follow-up colonoscopy. Bryant did win her appeal, but it took five months to get it resolved.

While TV ads for Cologuard say the cost of the test is covered by most insurance policies, they don't note that a follow-up colonoscopy may not be covered, CBS News reported.

Bryant said she wished those ads had given her some warning.

"I don't want to say it's a sham, but in a way, it's just kind of taking advantage of people. If it happened to me, I know that it's going to happen to a lot of people," Bryant said.

Cologuard is sold by Exact Sciences. Chairman and CEO Kevin Conroy acknowledged there's a problem and told CBS News the company has added new language to its website that says, "Millions of patients have access to this follow-up colonoscopy with no out-of-pocket cost, but not all do."

CBS News surveyed 11 of the largest health insurers in the United States to see what they would do in situations like Bryant's. Seven did not respond. The four who did said coverage decisions vary, and how much a consumer will pay depends on how doctors code the colonoscopy procedure.

Experts say Cologuard is a good screening tool, but unfortunately, "in some cases, people with a positive, noninvasive test like Cologuard will have to pay out of pocket to get their colonoscopy," University of Michigan's Dr. Mark Fendrick, who studies medical service pricing, told CBS News.

That could lead some people to pass on a colonoscopy, even if they have a risk of colon cancer, he noted.

"The fact that the people who are deemed to be at higher risk, that it's not easy financially or otherwise to get the colonoscopy, makes absolutely no sense to me," he told CBS News.

More information

Visit the American Cancer Society for more on colon cancer.

SOURCE: CBS News




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net